Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis
NCT00691028
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
327
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
TA-650 3 mg/kg
DRUG:
TA-650 6 mg/kg
DRUG:
TA-650 10 mg/kg
Sponsor
Tanabe Pharma Corporation